Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites [NA]
Completed clinical trial update on adapting the Bipolar Care Model for chronic care management in community-based health care sites. The sta…
-
FDA label_change · 2014-05-21FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
The FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) from Sumitomo Pharma America, resulting in changes to the …
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents [Phase 3]
A Phase 3 trial evaluated the effectiveness of combining Family-Focused Treatment with pharmacotherapy for adolescents with bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Reproductive Function and Mood in Women With Bipolar Disorder
A completed Stanford-sponsored clinical trial evaluated reproductive function alongside mood in women with bipolar disorder.
-
FDA approval · 2014-05-15FDA Approved: OLANZAPINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic olanzapine manufactured by Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study [Phase 4]
Phase 4 open-label randomized study comparing quetiapine XR alone versus quetiapine XR with lithium in acute bipolar mania; the trial was te…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI) [Phase 1]
Phase 1 completion of a trial evaluating individually based psychosocial rehabilitation for older adults with serious mental illness, includ…
-
CLINICAL_TRIALS research · 2014-05-07Clinical Trial Update: "Mindfulness vs Psychoeducation in Bipolar Disorder" [NA]
A clinical trial comparing mindfulness versus psychoeducation for individuals with bipolar disorder and depressive symptoms; sponsored by In…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder [Phase 3]
Phase 3 trial comparing aripiprazole (Abilify) to placebo in children with subsyndromal bipolar disorder has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device [NA]
Completed clinical trial evaluating low field magnetic stimulation (LFMS) for mood disorders, with results posted in 2014.
-
FDA approval · 2014-04-28FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's label…
-
FDA approval · 2014-04-24FDA Approved: LAMOTRIGINE EXTENDED RELEASE — Supplemental Application (Par Health USA, LLC)
FDA approves a supplemental abbreviated new drug application for Lamotrigine Extended Release from Par Health USA, LLC.
-
FDA approval · 2014-04-22FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for quetiapine fumarate submitted by BluePoint Laboratories. This action grants updated regulatory a…
-
CLINICAL_TRIALS trial_result · 2014-04-22Clinical Trial Update: Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad) [Phase 4]
Phase 4 clinical trial update examining switching to Ziprasidone to address adherence and psychotropic-related weight gain concerns in bipol…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder [Phase 4]
A Phase 4 trial of ziprasidone for generalized anxiety disorder in patients with bipolar disorder was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating the potential drug interaction between valproic acid and paliperidone extended-release in adults with schizophrenia…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: The Study of Effectiveness Repetitive Transcranial Magnetic Stimulation in Bipolar Depression [NA]
A study evaluating the effectiveness of repetitive transcranial magnetic stimulation for bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression [Phase 3]
A 24-week extension study of lurasidone in adults with Bipolar I Depression reports long-term safety and efficacy data.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression [Phase 4]
An update on a Phase 4 clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for bipolar depression, sponsored by Mc…
-
FDA approval · 2014-03-28FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for GEODON (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder [Phase 4]
A Phase 4 trial evaluating quetiapine XR for cognitive and functional impairment in clinically stable bipolar disorder patients was terminat…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder [Phase 1, Phase 2]
An update on a completed Phase 1/Phase 2 clinical trial evaluating the effectiveness of family-focused psychoeducation for adolescents with …
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Early Family-Focused Treatment for Youth at Risk for Bipolar Disorder [NA]
The document reports that a clinical trial evaluating early family-focused treatment for youth at risk for bipolar disorder has completed.
-
FDA approval · 2014-03-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Sun Pharmaceutical Industries.
-
FDA approval · 2014-03-18FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for DIVALPROEX SODIUM submitted by Bionpharma Inc.